Michele Bottosso

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Positive Breast Cancer

Gene Expression

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

NPJ breast cancer

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Michele Bottosso, Federica Miglietta, Grazia Maria Vernaci, Tommaso Giarratano, Maria Vittoria Dieci, Valentina Guarneri, Gaia Griguolo
Gene-expression assays to tailor adjuvant endocrine therapy for HR+/HER2- breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Michele Bottosso, Federica Miglietta, Grazia Maria Vernaci, Tommaso Giarratano, Maria Vittoria Dieci, Valentina Guarneri, Gaia Griguolo
Gene Expression Assays to Tailor Adjuvant Endocrine Therapy for HR+/HER2- Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Michele Bottosso, Federica Miglietta, Grazia Maria Vernaci, Tommaso Giarratano, Maria Vittoria Dieci, Valentina Guarneri, Gaia Griguolo
Gene Expression Assays to Tailor Adjuvant Endocrine Therapy for HR+/HER2- Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Michele Bottosso, Federica Miglietta, Grazia Maria Vernaci, Tommaso Giarratano, Maria Vittoria Dieci, Valentina Guarneri, Gaia Griguolo
Gene Expression Assays to Tailor Adjuvant Endocrine Therapy for HR+/HER2- Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Michele Bottosso, Benjamin Verret, Olivier Caron, Nadim Hamzaoui, Éric Pasmant, François-Xavier Danlos, Pascaline Boudou-Rouquette, Arunya Srikaran, Hélène Blons, Valentina Guarneri, Sherene Loi, Fabrice Andre, Camille Tlemsani
Efficacy and Safety of Immune Checkpoint Blockade in Patients With Li-Fraumeni Syndrome. JCO precision oncology 8 (2024)
Federica Miglietta, Moira Ragazzi, Bethania Fernades, Gaia Griguolo, Davide Massa, Fabio Girardi, Michele Bottosso, Alessandra Bisagni, Giovanni Zarrilli, Francesca Porra, Daniela Iannaccone, Leocadia Dore, Mariangela Gaudio, Giacomo Santandrea, Angelo Paolo Dei Tos, Marcello Lo Mele, Rita De Sanctis, Alberto Zambelli, Giancarlo Bisagni, Valentina Guarneri, Maria Vittoria Dieci
A prognostic model based on residual cancer burden and tumor-infiltrating lymphocytes on residual disease after neoadjuvant therapy in HER2+ breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Federica Miglietta, Gaia Griguolo, Michele Bottosso, Tommaso Giarratano, Marcello Lo Mele, Angelo Paolo Dei Tos, Matilde Cacciatore, Elisa Genovesi, Debora De Bartolo, Grazia Maria Vernaci, Ottavia Amato, Francesca Porra, PierFranco Conte, Valentina Guarneri, Maria Vittoria Dieci
HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment. NPJ breast cancer 8 (1) (2022)
Benjamin Verret, Michele Bottosso, Sofia Hervais, Barbara Pistilli
The Molecular Predictive and Prognostic Biomarkers in Metastatic Breast Cancer: The Contribution of Molecular Profiling. Cancers 14 (17) (2022)
Maria Vittoria Dieci, Gaia Griguolo, Michele Bottosso, Vassilena Tsvetkova, Carlo Alberto Giorgi, Grazia Maria Vernaci, Silvia Michieletto, Silvia Angelini, Alberto Marchet, Giulia Tasca, Elisa Genovesi, Enrico Cumerlato, Marcello Lo Mele, PierFranco Conte, Valentina Guarneri
Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy. NPJ breast cancer 7 (1) (2021)
Federica Miglietta, Gaia Griguolo, Michele Bottosso, Tommaso Giarratano, Marcello Lo Mele, Angelo Paolo Dei Tos, Matilde Cacciatore, Elisa Genovesi, Debora De Bartolo, Grazia Maria Vernaci, Ottavia Amato, PierFranco Conte, Valentina Guarneri, Maria Vittoria Dieci
Evolution of HER2-low expression from primary to recurrent breast cancer. NPJ breast cancer 7 (1) (2021)
Federica Miglietta, Gaia Griguolo, Michele Bottosso, Tommaso Giarratano, Marcello Lo Mele, Angelo Paolo Dei Tos, Matilde Cacciatore, Elisa Genovesi, Debora De Bartolo, Grazia Maria Vernaci, Ottavia Amato, PierFranco Conte, Valentina Guarneri, Maria Vittoria Dieci
Author Correction: Evolution of HER2-low expression from primary to recurrent breast cancer. NPJ breast cancer 7 (1) (2021)